Collector
Giriş Yap
Alterity wins key FDA alignment for pivotal neurological trial | Collector
Alterity wins key FDA alignment for pivotal neurological trial
Stockhead

Alterity wins key FDA alignment for pivotal neurological trial

This results from a successful end-of-phase II meeting, in which the FDA agreed with ATH's proposed phase III MSA trial ... Read More The post Alterity wins key FDA alignment for pivotal neurological trial appeared first on Stockhead .

Go to News Site
Google Play Google Play App Store App Store
Pauline Hanson blasts Australian universities, rev
PerthNow
Pauline Hanson blasts Australian universities, reveals foreign student policy plan to keep dropouts away
 Therese Ebbett: Prison term suspended for 51-year-
The West Sport
Therese Ebbett: Prison term suspended for 51-year-old Albany woman after house search reveals drug dealing
 Forget craft beer and gin - this is one of the nex
Canberra Times
Forget craft beer and gin - this is one of the next big epicurean trends
 A royal author has weighed in on the Princess of W
Sky News Australia
A royal author has weighed in on the Princess of Wales' relationship with the media and how her use of "hyper-emotive content" has placed her in the press' good books.
Stockhead
Clever Culture snags another big fish with CSL Behring clien
Stockhead
Clever Culture snags another big fish with CSL Behring client deal
 Mont Royal bulks up Ashram with $2bn rare earths plan
Stockhead
Mont Royal bulks up Ashram with $2bn rare earths plan
 Riversgold’s overlimit multimetal results strengthen Saint J
Stockhead
Riversgold’s overlimit multimetal results strengthen Saint John case
 Postman’s Gully delivers district-scale potential for Koonen
Stockhead
Postman’s Gully delivers district-scale potential for Koonenberry Gold
 Gold anomalies put Corporate James in Nimy’s sights at Mons
Stockhead
Gold anomalies put Corporate James in Nimy’s sights at Mons
 Lunch Wrap: Rate fears hit miners as defence tech muscles in
Stockhead
Lunch Wrap: Rate fears hit miners as defence tech muscles into the ASX 200
 Donald Phase 2 lifts economics of Astron’s rare earths proje
Stockhead
Donald Phase 2 lifts economics of Astron’s rare earths project
 StockTake: HRE strengthens leadership ahead of maiden drilli
Stockhead
StockTake: HRE strengthens leadership ahead of maiden drilling
 PolarX hits more ‘hyper grade’ copper as Northern Star JV dr
Stockhead
PolarX hits more ‘hyper grade’ copper as Northern Star JV drilling begins
 Caspin identifies Kelpie lookalike tin target at Moss
Stockhead
Caspin identifies Kelpie lookalike tin target at Moss
 Lithium Plus gears up for 2026 drilling campaign at Bynoe
Stockhead
Lithium Plus gears up for 2026 drilling campaign at Bynoe
 Break it Down: LTR secures first US commercial deal for ROXU
Stockhead
Break it Down: LTR secures first US commercial deal for ROXUS
 From Growth to Income: Why the budget could reshape property
Stockhead
From Growth to Income: Why the budget could reshape property investing
 Nordic extends Angesneva with gold-copper-silver hit
Stockhead
Nordic extends Angesneva with gold-copper-silver hit
 StockTake: AuKing fires off the rare earth blocks for maiden
Stockhead
StockTake: AuKing fires off the rare earth blocks for maiden Malawi drilling
 StockTake: Regener8 starts work at Srebrenica North
Stockhead
StockTake: Regener8 starts work at Srebrenica North
 Chariot Resources rides its expanded Resurgent project on re
Stockhead
Chariot Resources rides its expanded Resurgent project on revived lithium price
 Morning Feed: What’s cooking on the ASX?
Stockhead
Morning Feed: What’s cooking on the ASX?
 Long Shortz with EBR: $150m cap raise marks significant mile
Stockhead
Long Shortz with EBR: $150m cap raise marks significant milestone on path to profitability
 Long Shortz with Xenitra: OPAL surpasses $1.1 million in jus
Stockhead
Long Shortz with Xenitra: OPAL surpasses $1.1 million in just seven weeks